Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on TrackEx-U.S.
Genomes are key to unlocking life's evolutionary history. The presence and absence of certain genetic sequences and mutations ...
TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. Preserves DNA integrity in challenging clinically ...
Q3 2025 Earnings Call November 5, 2025 2:00 AM ESTCompany ParticipantsIvan Vindheim - Chief Executive OfficerKristian Ellingsen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback